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Abstract
Background: Pancreatic occlusion failure (POF) after distal pancreatectomy remains a common source
of morbidity. Here, we review our experience with distal pancreatectomy and attempt to identify factors
which influence POF rates.
Patients and Methods: One hundred sixty-nine distal pancreatectomies were performed between
2002 and 2007. Review of the computerized medical records and physician office records was performed
for all patients. Univariate and multivariate analyses were performed to determine factors which might
influence the incidence of POF. The data set was analysed for factors which might influence the
pancreatic occlusion rate. Analysis included patient and disease characteristics including: age, gender,
body mass index (BMI), diagnosis, consistency of the pancreas and history of pancreatitis, as well as
intra-operative variables including: surgeon, absorbable mesh reinforcement and operative approach.
Results: POF was the most common peri-operative complication. POF was identified in 32 out of 169
patients (19%). Transection technique (hand sewn, stapled, stapled with mesh) and procedure complexity
were factors associated with differences in POF rates by both univariate and multivariate analyses. POF
was identified in 7 out of 70 patients (10%) when an absorbable mesh was utilized, and 25 of 99 patients
(25%) when mesh was not utilized (P < 0.02).
Discussion: These data suggest that a randomized controlled trial will be required to determine if mesh
reinforcement reduces the rate and severity of POF after distal pancreatectomy.
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Introduction
There have been dramatic improvements in the care of patients
undergoing pancreatic resection. This is best exemplified by
several large case series of pancreaticoduodenectomy from mul-
tiple centres demonstrating mortality rates of less then 2%.1–8
Unfortunately, the improvements in operative technique, peri-
operative care, surgical materials and instrumentation have not
lead to a dramatic reduction in pancreatic occlusion failure (POF)
after distal pancreatectomy. This is evidenced by recent studies
reporting the persistence of the problem with many centres
describing fistula rates of approximately 20–30%.1,2,9 POF is one of
themore extensively investigated issues facing pancreatic surgeons
and a variety of operative techniques, drainage regimens and
adjunctive hormonal analogues have been studied.3,4,7,10–22
Although often promising in small case series, none have had a
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dramatic impact on the occlusion failure rate when subjected to a
randomized controlled trial.5,17,23–26
The severity and subsequent sequelae of POF after distal
pancreatectomy varies considerably.27,28 The majority of patients’
leaks will be identified early and many leaks are controlled with an
intra-operatively placed drain. In other patients, occlusion failure
may require hospital readmission, emergency department visits,
percutaneous or open drainage, prolonged antibiotic therapy and
radiological surveillance.While there is no clear consensus on the
definition of a POF or its severity, most experts agree that the
prevention of POF after distal pancreatectomy is critical in achiev-
ing an uneventful post-operative course and will significantly
reduce costs.
A definition and severity grading system for POF has recently
been proposed.29 In this system, the severity of the intervention
required and the overall outcome define the severity grading into
5 grades. Grade 1 is any deviation from normal post-operative
course without the need for intervention. Grade 2 requires phar-
macological treatment and grade 3 requires intervention. Grade 3
is further divided in Grade 3a and 3b depending on the need for
general anaesthesia. Grade 4 results in permanent disability and
grade 5 results in death.29
Here we review our experience with distal pancreatectomy over
a 5-year period (2002–2007). During this same time period we
introduced the use of an absorbable mesh. The rational for utiliz-
ing the mesh was based on the success with reduction in leaks in
other areas of surgery including lung reduction30,31 and gastric
bypass.32,33 All operative techniques were included in this analysis.
This analysis sought to determine if the utilization of mesh or any
other variables were associated with a change in POF rates after a
distal pancreatectomy.
Methods
A retrospective review (March 2002–May 2007) of all distal pan-
createctomies performed within the section of HPB/GI surgery at
Washington University Medical Center/ Barnes-Jewish Hospital
was performed. One hundred and sixty-nine patients underwent
distal pancreatectomies from 22 March 2002 to 30 May 2007. All
operative indications and both open and laparoscopic approaches
were included in the analysis. All procedures were performed by
one of six surgeons in the group. The choice of closure was at the
discretion of the surgeon and there was no standard method
applied to hand closure, mesh type or stapler utilized.
The main outcome measure was failure of occlusion of the
pancreatic stump leading to leakage within the first 30 days of the
post-operative period. POF included both fistulas and fluid collec-
tions (sterile or infected) except for ascites, unless it was shown to
be amylase rich. POFwas defined as a clinically relevant pancreatic
fistula, fluid collection or other complication arising from leakage
of pancreatic juice from the pancreatic stump. The term clinically
relevant means that the event resulted in interventions that are not
part of the normal post-operative course (e.g. antibiotics, drain-
age).29 To be considered a POF which was clinically relevant there
had to be amylase-rich fluid obtained from an intra-operatively
placed drain at or beyond post-operative day 10 of at least 30 ml
with a concentration three or more times greater than normal
serum levels.24,34 Fluid collections were detected by post-operative
CT scan. Any fluid collection or abscess requiring a drainage pro-
cedure was considered a fistula without regard to the amylase level.
CT scans were obtained when clinically indicated [i.e. elevated
white blood cells (WBC), persistent fevers, haemodynamic insta-
bility, unrelenting nausea and vomiting, abdominal pain, etc).
Information was obtained from hospital and physician records
and supplemented with information from the primary surgeons’
records as needed and available. Groups were analysed for POF,
morbidity and length of stay (LOS). Potential confounding vari-
ables were assessed to include: age, gender, operative approach,
operative surgeon and extent of procedure. Extensive procedures
were defined as partial or complete resection of a contiguous
organ including: stomach, colon, liver and kidney. Splenectomy,
adrenalectomy and/or extended lymphadenectomy were excluded
from the grouping of extended procedure. Secondary outcome
measures were assessed including: re-operations, other non-
surgical therapeutic interventions (i.e. drainage via interventional
radiology or CT), hospital readmissions and mortality.
Means were compared using the Student’s t-test and propor-
tions using the c2 or Fisher’s exact tests. Time-to-event data were
analysed using Cox proportional hazard models. For all analyses,
a P-value of <0.05 was set as the threshold for statistical signifi-
cance. Software used for statistical analysis was GraphPad Prism
(GraphPad Software Inc., La Jolla, CA, USA) SAS 9.1.3 (SAS
Institute Inc., Cary, NC, USA). This retrospective review was
approved by the Human Studies Committee at Washington
University.
Results
One hundred and sixty-nine patients (73 males and 96 females)
underwent a distal pancreatectomy between March 2002 and May
2007 (Table 1). The median age of the patients at resection was 59
years (mean 57, range 23–84). Malignant or pre-malignant neo-
plasia (IPMN or MCN) accounted for the majority of lesions
resected (73%). Of the primary pancreatic tumours, the final
pathological diagnosis included 36 with pancreatic adenocarci-
noma (21%). There were 23 neuroendocrine neoplasms (14%), 62
cystic neoplasms (37%, 7 of these were cystic adenocarcinomas)
and 3 solid/pseudo-papillary neoplasms (2%). There were 27
patients who underwent distal pancreatectomies for non-
pancreatic primaries. This included 20 patients with direct exten-
sion of cancer from a contiguous organ and 5 with an isolated
pancreas metastasis. Non-pancreatic pathology included renal cell
carcinoma (6), sarcoma (5), adrenocortical carcinoma (4), gastric
carcinoma and lymphoma (12). Complex or extensive operations,
as defined by removal of one or more contiguous organs, were
performed on 63 out of the 169 patients (37%) including 24
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partial or complete gastrectomies, 18 partial colectomies, 12
nephrectomies and 9 partial hepatectomies.
Patient demographics, pathology and procedures were analysed
in order to identify significant changes, if any, in surgical indica-
tions, patient population or operative technique over the study
period. Table 2 highlights some findings of this analysis. The
patient population did not appear to differ between years. For
example, the average patient age ranged from 51–63 with no sig-
nificant change over time. Surgical indications and percentage of
patients with a final diagnosis of cancer remained fairly constant.
The number of distal pancreatectomies has increased in each
study year. Laparoscopic resections have increased over the study
period in both absolute number and as a percentage of all distal
pancreatectomies (P = 0.0002, Table 2). Use of absorbable mesh to
reinforce the pancreatic transection line has increased over the
study period (P < 0.0001). The POF rate has varied over time
ranging from amaximum of 29% in 2003 and a minimum of 13%
in 2005. There was not a statistically significant trend towards a
reduction in the POF rate or total LOS for the entire population of
patients over the study period.
Univariate and multivariate analyses were carried out to iden-
tify factors which may be associated with POF after distal pancre-
atectomy (Table 3). In univariate analysis, complex or extended
resections were significantly associated with an increased POF
rate, when compared with those undergoing routine surgery (P =
0.016). Utilization of mesh was associated with a reduction in the
POF rate, when compared with patients whose pancreatic stumps
were closed with other techniques (P = 0.003). Although it is true
that POF was identified in 7 out of 70 patients (10%) when an
absorbable mesh was utilized and 25 out of 99 patients (25%)
whenmesh was not utilized (P < 0.02 c2, two groups), a closer look
at the primary data demonstrates that the outlier in the analysis is
the hand sewn technique and that the difference between stapled
and stapled with mesh reinforcement is more modest and not
statistically different. Analysis of all other factors including lap-
aroscopic surgical approach, patient characteristics (age, gender),
diagnosis and operative surgeon were not statistically significant.
Multivariate analysis for POF indicated that closure type and
complexity of procedure both raised the probability of occlusion
failure. Suturing had a probability about 4.4 times higher than
mesh or stapling without mesh. Extended or complex resections
had a probability of POF about 3.3 times higher then routine
procedure, after adjusting for the effect of closure type. The effect
of closure type and complexity of surgery are independent, with
little interaction effect on the outcome of POF (Table 4).
Peri-operative morbidity andmortality are displayed in Table 5.
There was no mortality in any group. A thorough chart review
indicated that the majority of peri-operative morbidity was
Table 1 Clinicopathologic descriptors
Demographics
Number 169
Age mean (median) 57 (59)
Gender (male : female) 73:96
Pathologic Diagnosis
Adenocarcinoma 42 (25%)
Chronic pancreatitis 20 (12%)
Benign cystic neoplasmsa 55 (33%)
Neuroendocrine neoplasm 24 (14%)
Non-pancreatic pathology 25 (15%)
Solid and pseudo papillary neoplasm 3 (2%)
Operative variables
Laparoscopic approach 36 (21%)
Complex or extensive procedure 63 (37%)
Outcomes
Pancreatic occlusion failure 32 (19%)
Intra-operative drain retained 15
Radiologically placed drain 15
Re-operation 3
Peri-operative mortality 0
Median length of stay (days) 9.4
aCystic neoplasms included serous cystadenomas, mucinous cystic neo-
plasms and intraductal papillary mucinous tumours.
Table 2 Patient characteristics' trends over time
2007 1st Q (1st) 2006 2005 2004 2003 2002
N 15 38 31 32 28 25
Age 53 61 53 59 57 63
Gender (male : female) 10:5 18:20 13:18 14:18 7:21 10:15
Neoplastic lesion 11 27 21 27 20 16
Laparoscopic approacha 7 (47) 16 (42) 7 (23) 3 (9) 1 (4) 2 (8)
Buttressed material useda 15 (100) 28 (74) 21 (68) 7 (22) 0 (0) 0 (0)
POF 3 (20) 6 (16) 4 (13) 6 (19) 8 (29) 4 (16)
Median length of stay 6.1 9.9 10 9 9 11
Mortality 0 0 0 0 0 0
aIndicates statistically significant change over time.
HPB 27
HPB 2009, 11, 25–31 © 2009 International Hepato-Pancreato-Biliary Association
related to the presence or absence of POF. Table 5 shows the total
length of stay (mean and median) for each group. Total length of
stay includes the initial length of stay (peri-operative) added to
any readmission or outpatient procedure days divided by the
number of patients in that group. This formula is an attempt to
capture the potential cost or benefit experienced by the patient as
a result of a difference in POF rates.With this we saw no difference
in length of stay between all three groups. While not statistically
significant, it may be clinically significant to point out that
patients who received buttress material or underwent staple
closure of the pancreatic stump required less treatment for POF
(drain maintenance, radiological intervention, re-operation) then
patients whose stumps were closed with suture.
Two staplers accounted for the majority of stapled pancreas
transections. These were the Echelon™ 60 (Ethicon Endo-Surgery
Inc., Cincinnati, OH, USA) or Autosuture™ Endo GIA (Covidien,
Mansfield, MA, USA). In the large majority of patients a thick
tissue staple load (green) was utilized. There was no difference in
leak rates when the data were stratified by stapler, or staple size
(data not shown). In 63 patients the Seamguard® product (Gore
Inc., Flagstaff, AZ, USA) was utilized to reinforce the staple line
and in 7 patients the Peristrip Dry® (Synovis Surgical, St. Paul,
MN, USA) was utilized to reinforce the staple line. There was no
difference in leak rate by reinforcement type (data not shown).
When performing a hand-sewn closure, surgeons generally per-
formed a separate ligation of the pancreatic duct followed by
reinforcement of the pancreas parenchyma. The technique varied
slightly by surgeon (choice of suture, fish mouthing of the pan-
creas parenchyma) but was consistent for each surgeon. There was
no difference in leak rates for the individual surgeons when analy-
sis of the hand-sewn technique was performed (data not shown).
It is our routine to leave a drain with all distal pancreatectomies.
The intra-operatively placed drain was maintained for POF in 15
Table 3 Univariate logistic regression analysis for pancreatic occlusion failure
Variables N Events OR 95%CI P-values
Ages 0.12
23–50 47 6 1.0
50–65 64 16 2.28 (0.82,6.36)
>65 58 10 1.42 (0.48,4.25)
Gender 0.10
Female 73 14 1.00
Male 96 18 1.92 (0.88,4.17)
Diagnosis
Adenocarcinoma 36 7 1.04 (0.41,2.65) 0.93
Neuroendocrine 23 5 1.22 (0.42,3.59) 0.71
Cystic 62 11 0.88 (0.39,1.98) 0.76
Chronic pancreatitis 18 3 0.84 (0.23,3.10) 0.80
Pseudopapillary 3 1 2.18 (0.19,24.78) 0.53
Non-pancreatic 27 5 0.97 (0.34,2.79) 0.95
Extent of resection 0.016
Routine 106 14 1.00
Extended 63 18 2.63 (1.20,5.76)
Operative approach 0.18
Open 133 24 1.00
Laparoscopic 36 8 0.47 (0.15,1.44)
Closure 0.003
Suture 55 18 1.00
Stapler 44 7 0.39 (0.14,1.04)
Mesh 70 7 0.23 (0.09,0.60)
Table 4 Multivariate logistic regression for pancreatic occlusion
failure
Variables N OR 95% CI P-values
Closure
Suture 18 4.57 (1.74,11.98) 0.002
Staple 7 1.73 (0.56,5.32) 0.34
Mesh 7 1.00
Operative approach
Extended 18 3.26 (1.37,7.75) 0.007
Routine 14 1.00
OR, odds ratio; CI, confidence interval.
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out of 169 patients (9%). Additional drains were required in 15
patients. These data suggest that routine intra-operatively placed
drains capture about one-half of clinically significant POF.
Stratifying our POF-related complications based on use of
mesh reinforcement (Table 6), we found that mesh reinforcement
was associated with fewer grade 3a complications (P = 0.02).Mesh
placement demonstrated no difference for complications which
required pharmacological treatment alone, although the capture
rate for less severe complications is more than likely incomplete.
Over this study period there were no life-threatening complica-
tions requiring ICUmanagement (Grade 4) and no deaths (Grade
5) were observed.
Discussion
While survival after pancreatic surgery has improved dramatically,
the morbidity remains unacceptably high. This review focused on
POF which remains the most common cause of morbidity after
distal pancreatectomy. In modern prospective series, the overall
morbidity after distal pancreatectomy may be as high as 47%2 and
POF is the basis for more than half of this morbidity.1,2,9 Uniform
definition and severity grading of pancreatic stump closure
remain controversial.29,35,36 In this study, we found that the severity
and outcome-based complication scale best met our needs.29
While there is an obvious clinical and psychological benefit to an
uneventful recovery from surgery, it is also important to note that
there are significant societal benefits in reducing the rate of POF.
For example, the average patient with POF will utilize significantly
more health care resources and will incur a cost approximately
twice that of a patient without POF.37
We began using mesh to reinforce a linear stapler in a sporadic
fashion in 2004. We were encouraged by our initial experience
and performed a prospective study over approximately a 1-year
period.38 In the prospective series of 29mesh reinforced resections,
there was a single instance of POF for a rate of 3.5%.While the data
was encouraging, there were several limitations and confounding
factors. For example, althoughwe planned to utilize themesh in all
patients during the study period alternative closures were utilized
in 11 patients and 4 of those developed POF (36%).We postulated
that we may have unwittingly selected patients at less risk for POF
or that the mesh was not applicable for patients at the highest risk
for POF. We suggested that a randomized clinical trial would be
required to truly elucidate the effectiveness of the mesh.
One of the driving factors for conducting this analysis was to
convince ourselves that this issue was worthy of a randomized
controlled trial and attempt to determine the power required for
such a trial. As far as we know this case series represents the largest
experience with mesh reinforcement38,39 and doubles the total
published experience.
In our present series, mesh reinforcement of a stapled transec-
tion was associated with a reduced POF rate by both the univari-
ate and multivariate analyses. These data suggest that the
utilization of mesh was associated with a 60% reduction in POF
rate (25% without mesh, 10% with mesh, P < 0.02). However,
when one breaks down closure technique we find no significant
difference between mesh reinforcement and staple closure effect
on POF. There also appeared to be no reduction in the mean/
median total length of stay for patients who received mesh
reinforcement when compared with those who did not.
Table 5 Peri-operative morbidity
Mesh (n = 70) Stapler (n = 44) Suture (n = 55) P-values
Mean age (years) 49 (29–82) 55 (23–82) 59 (24–84) 0.17
Gender distribution 38 F : 32 M 25 F : 19 M 32F : 23M 0.84
Neoplastic lesion 53/70 (76%) 29/44 (66%) 43/55 (78%) 0.50
Laparoscopic approach 24/70 (34%) 4/44 (10%) 4/55 (7%) <0.0001
Complex/extensive operation 18/70 (26%) 24/44 (55%) 19/55 (35%) 0.013
POF 7/70 (10%) 7/44 (16%) 18/55 (33%) 0.006
Mean LOS (median days) 10.1 (8) 10.7 (8) 12.3 (9) 0.36
60-day mortality 0 0 0
Treatment of POF
Surgical drain retained 3 4 8 0.76
IR/CT drain 3 3 9 0.13
Re-operation 0 1 2 0.62
POF, pancreas occlusion failure; LOS, length of stay; IR/CT drain, international radiology/CAT Scan guided drain.
Table 6 Classification of pancreatic occlusion failure
Non-Mesh
group (n = 99)
Mesh group
(n = 70)
P-values
Grade 1 6 1 NS
Grade 2 5 2 NS
Grade 3 16 3 0.02
3a 13 3 0.02
3b 3 0 NS
Grade 4/5 0 0 NS
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Concurrently, it is important to point out that we used a larger
percentage of mesh reinforcement in each successive year and yet
the POF rate for the entire population of patients was not sig-
nificantly reduced over the course of the study period.
We found a significant reduction in the leak rate when staplers
are utilized (with or without mesh) when compared with the
hand-sewn technique.As our group preferentially utilizes a stapler
whenever technically feasible we can not utilize these data to
comment on the issue of hand sewn versus the stapled closure of
the distal pancreas. Following our prospective series on the poten-
tial benefit of utilizing the stapler with mesh we have attempted to
utilize a mesh-covered stapler whenever technically possible. In
doing so we have identified situations in which we have discovered
that a stapler (with our without mesh) is not an ideal approach to
closure. In our opinion it is in pushing the limitations of the
mesh-covered stapler which is partly responsible for the reduction
in apparent benefit between our initial experience and this series.
As we continue to gain experience with the stapler we have found
that the triangular pancreas, the very thick pancreas (>1.5 cm), the
very firm or non-compressible pancreas and a transection plain to
the right of the gastro-duodenal artery are suboptimal situations
for a stapled closure. Future studies should aim to collect more
details regarding the relevant pancreatic anatomy and consistency.
Precise measures of these variables will enhance our ability to
determine the ideal scenario for stapler transection and mesh
reinforcement.
There was an absolute percentage difference in POF rate of 10%
versus 16% in favour of mesh reinforcement of the stapler. Review
of the literature suggests that the leak rate for mesh reinforcement
may be less than 5% and that the leak rate for stapled transection
without mesh may be as high as 20%.Utilizing these numbers and
our current series as a best and worst case scenario a trial would
require as many as 76–486 patients per group to attain a power of
80% at a 0.05 significance level. In our opinion this trial will best
be achieved with a multiple-center randomized control design.
After carefully reviewing our experience and the literature, our
group believes that there is equipoise on this issue and are in the
process of attempting to organize a multi-centre prospective ran-
domized trial.
There were several unintended conclusions which arose from
analysing thesedata.First, extended resectionswere associatedwith
an increased POF rate. While it would be expected that more
extensive surgery might result in increased mortality, or length of
the stay, the reason for the increase in the POF rate is unknown. It
might be speculated that extensive resections inour group included
cases inwhich the pancreaswas peripherally involved (i.e. sarcoma,
gastric carcinoma). In patients where the pancreas is expected to be
relatively soft,5 more POFmight be expected. It is also possible that
the blood supply to the distal pancreasmay be reduced as a result of
the extent of resections.8,40 Patients requiring such large resections
might also bemalnourished and fail to seal appropriately. The data
are insufficient to clearly identify the cause but it is clear that larger
resections were associated with an increased risk for POF.
We also found that laparoscopic resection appeared safe and did
not differ in POF rates from open surgery. In fact the absolute
number and percentage of POF were less in the laparoscopic
group. This seemed counter intuitive because we found that lap-
aroscopy was more often performed for patients with cystic neo-
plasms where the pancreatic tissue is soft and therefore more
prone to POF. The equivalence of outcome in this setting is
encouraging for the continued expansion of minimally invasive
techniques in hepatobiliary surgery.
Lastly, we found that routinely placed drains were capable of
capturing POF and preventing the need for additional procedures
in 9% of the patients undergoing a distal pancreatectomy. In 169
patients there were 32 instances of POF (19%). In 15 out of the 32
POF (47%), the surgically placed drain was maintained as the only
required treatment.We are not aware that any group has prospec-
tively studied the question of routine drain placement in patients
undergoing a distal pancreatic resection. In one study, when
patients were randomized to receive a drain after pancreati-
coduodenectomy, there was an increase in complications.24 One
could argue for or against routine drainage after distal pancreate-
ctomy based on our data. In our opinion routine drains are cur-
rently indicated and will be required in our randomized clinical
trial. If the leak rate can be reduced routine drainage may even-
tually become unnecessary.
Conclusions
Absorbable mesh reinforcement of a pancreatic transection line
may reduce the POF rate associated with distal pancreatectomy.
Although there was increased utilization of mesh over the dura-
tion of the study period, there was not a significant reduction in
the POF rate for the entire population.Our group believes that the
incorporation of mesh shows promise as a method to reduce the
POF rate. The present work, while the largest review of the topic,
inadequately addresses the differences between mesh utilization
and stapler alone. A multi-institution randomized prospective
trial is needed to conclusively address this issue.
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